- Brett Emison | February 03, 2011 10:55 AM | Kansas City, MO
Category:
FDA & Prescription Drugs
In what may become fodder for the tort reform crowd, a French citizen has sued drug maker GlaxoSmithKline, blaming Glaxo's Parkinson's drug Requip for erratic behavior including persistent gambling...
- Brett Emison | October 27, 2010 12:15 PM | Kansas City, MO
Category:
Wrongful Death
Legal and safety news of interest from around the internet:
When sharing is bad: Judge orders shut down of LimeWire [Ashby Jones at WSJ]
Drug maker GlaxoSmithKline to pay $750 million...
- Brett Emison | October 18, 2010 11:30 AM | Kansas City, MO
Category:
FDA & Prescription Drugs
Earlier this summer, two independent studies confirmed that diabetes drug, Avandia, increases the likelihood of heart attack and bolstered claims that the side effect risks of the drug outweigh its...
- Brett Emison | July 14, 2010 2:26 PM | Kansas City, MO
Category:
FDA & Prescription Drugs
The Food and Drug Administration (FDA) began a two-day hearing yesterday to assess the risks and side effect dangers of the diabetes drug, Avandia.
Avandia was introduced more than a decade ago...
- Brett Emison | June 03, 2010 3:59 PM | Kansas City, MO
Category:
FDA & Prescription Drugs
Reuters news service and The Wall Street Journal have reported that the first case set for trial in the United States on Avandia's link to heart attacks and other serious side effects settled...
- Brett Emison | February 22, 2010 1:59 PM | Kansas City, MO
Category:
FDA & Prescription Drugs
The Wall Street Journal has reported that the Food and Drug Administration (FDA) has recommended that that GlaxoSmithKline's diabetes medicine, Avandia, be pulled from the market because of...